Drug facts
MoleculeAlendronate (Fosamax)
Generics already compete: 9 makers on the market. 26 A-rated products from 9 makers substitute at the counter.
Fosamax was first approved by the FDA on 09/29/1995 under NDA 020560; the application holder is Organon LLC A Sub of Organon and Co.
The latest NADAC for ALENDRONATE SODIUM 70 MG TAB is $0.26 per unit (as of 10/28/2026).
Holder Organon LLC A Sub of Organon and CoApplication NDA 020560Approved 09/29/1995
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Fosamax patent listed in the Orange Book Orange Book
- Later patents, other products
- Binosto 12/05/2031 Orange Book
02Competition
- Generics
- 9 generic makers Orange Book
- First generic approved
- 02/06/2008 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Alendronate profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.26 per unitALENDRONATE SODIUM 70 MG TAB, mid-priced of 3 strengths, as of 10/28/2026 CMS NADAC
- Latest recall
- 04/07/2026Class II, Alendronate Sodium, Hikma Pharmaceuticals USA Inc FDA enforcement
04Product
- Application holder
- Organon LLC A Sub of Organon and Co Orange Book
- Application
- NDA 020560 Orange Book
- First approved
- 09/29/1995 Orange Book
- Dosage forms
- solution; tablet
- Routes
- oral
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.